Phosphoric Acid

Phosphoric Acid

SCHEMBL9637431

CNCCC(Oc1ccc(OC(F)(F)F)cc1)c1ccccc1.O=P(O)(O)O

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A known ✓ P35348 1/20 0.66
HRH1 known ✓ P35367 1/20 0.66
OPRM1 known ✓ P35372 1/20 0.66
OPRK1 known ✓ P41145 1/20 0.66
KCNH2 known ✓ Q12809 1/20 0.66
SLC6A4 P31645 12/20 0.66
MEN1 O00255 5/20 0.66
KMT2A Q03164 5/20 0.66
LMNA P02545 4/20 0.66
CYP2D6 P10635 4/20 0.66
CYP3A4 P08684 4/20 0.66
CYP2C19 P33261 3/20 0.66
CYP1A2 P05177 3/20 0.66
NPC1 O15118 2/20 0.66
MTOR P42345 2/20 0.66
RAB9A P51151 2/20 0.66
SLC6A2 P23975 2/20 0.66
HTR2C P28335 2/20 0.66
SLC6A3 Q01959 2/20 0.66
TP53 P04637 2/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoxetine SCHEMBL9715830 0.88 SLC6A4 (0.86) SLC6A4MEN1KMT2ALMNACYP2D6
Fluoxetine SCHEMBL8467346 0.80 SLC6A4 (1.00) SLC6A4MEN1KMT2ALMNACYP2D6
Fluoxetine SCHEMBL33947 0.80 SLC6A4 (1.00) SLC6A4MEN1KMT2ALMNACYP2D6
R-Fluoxetine SCHEMBL1200433 0.80 SLC6A4 (1.00) SLC6A4MEN1KMT2ALMNACYP2D6
Fluoxetine SCHEMBL570572 0.80 SLC6A4 (1.00) SLC6A4MEN1KMT2ALMNACYP2D6
Fluoxetine SCHEMBL8353 0.80 SLC6A4 (1.00) SLC6A4MEN1KMT2ALMNACYP2D6
Fluoxetine SCHEMBL6008121 0.80 SLC6A4 (0.88) SLC6A4MEN1KMT2ALMNACYP2D6
Fluoxetine SCHEMBL8722258 0.80 SLC6A4 (0.88) SLC6A4MEN1KMT2ALMNACYP2D6
SCHEMBL8197696 0.79 SLC6A4 (1.00) SLC6A4MEN1KMT2ALMNACYP2D6
SCHEMBL5011928 0.79 SLC6A4 (1.00) SLC6A4MEN1KMT2ALMNACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0336753-B1 IMPROVEMENTS IN OR RELATING TO PROPANAMINE DERIVATIVES ELI LILLY AND COMPANY (US) 1992-07-08 EP disclosed
EP-0336753-A1 Improvements in or relating to propanamine derivatives ELI LILLY AND COMPANY (US) 1989-10-11 EP disclosed